BioSpace

MAY 6, 2021

With 2020 holding a record number of biotech IPOs, this year is lining up to come close. Three more Bay Area life science companies are just about ready to hit the Nasdaq, adding to the growing list for 2021.

Life Science 98

Life Science 98

STAT News

JANUARY 8, 2023

SAN FRANCISCO — What should be a triumphant return to the global biotech industry’s biggest annual event, “JPM Week,” after a two-year hiatus is turning as gloomy as Bay Area weather, with industry executives forecasting economic troubles in the year ahead. Continue to STAT+ to read the full story…

98

98

STAT News

APRIL 11, 2023

And while that fact can make matching bone marrow and organ transplants torturously difficult, a Bay Area biotech believes it can harness immune diversity to treat a range of deadly cancers. No two people have quite the same immune system.

Genetics 98

Genetics Development 98

STAT News

DECEMBER 15, 2022

Bay Area biotech Guardant Health on Thursday announced results from a massive trial of its blood-based test for the early detection of colon cancer that, while good enough for Medicare reimbursement, underwhelmed observers.

Trials 98

Trials Marketing 98

BioTech 365

OCTOBER 19, 2021

GeneTether” or the “Company”), a Bay Area biotech company focused on developing … Continue reading → GeneTether Announces Organizational Changes Designed to Support Continued Growth GeneTether Announces Organizational Changes Designed to Support Continued Growth BERKELEY, Calif.,

Development 40

Development 40

Drug Discovery World

NOVEMBER 2, 2022

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. While 2021 was the highest year on record for investments into UK biotech and life sciences companies, it looks unlikely that the sector will be able to build on this success in 2022. . billion ($1.7 In total, £14.9

Life Science 52

Life Science Clinical Trials Clinical Trials Marketing 52

XTalks

JULY 29, 2022

Astellas Pharma has announced plans to build an integrated biotech facility at 480 Forbes Boulevard, South San Francisco. Astellas will invest around $70 million to build the new biotech facility, which will have state-of-the-art research laboratories and co-working spaces.

Gene Therapy 59

Gene Therapy Gene Manufacturing Development 59

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. Has the area become the Silicon Valley of biotech?’, Dr Mansley also comments that the multitude of biotech and pharma companies in the Greater Boston region means that people regularly move organisations.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Drug Discovery World

OCTOBER 18, 2022

This article spotlights the driving forces behind Basel’s snowballing reputation, and notes some of the oncology and immunotherapy success stories arising from this innovative biotech powerhouse. . BaseLaunch also introduced the team to Dr Søren Mouritsen, an experienced biotech entrepreneur who is now Engimmune’s CEO.

Life Science 52

Life Science Engineer Research Clinical Trials 52

Placebo Control

SEPTEMBER 25, 2013

I met Nadia Bracken on my last trip out to the San Francisco bay area. But that doesn't stop me from realizing that a lot of great insight about drug development – especially when it concerns small biotechs – is coming from the investment community. To say Nadia is driven is to make a rather silly understatement. Nadia is driven.

Development 40

Development Drugs Clinical Trials Clinical Trials 40

The Pharma Data

OCTOBER 28, 2020

Working in Houston, for a biotech company, I think is great,” Watowich said. It’s not that they don’t have money…most of the money is from pipeline and it’s hard to get them to understand that investing in biotech per se isn’t really that different from doing a very deep offshore oil well. Life Sciences Markets at JLL.

Life Science 40

Life Science Marketing Development Clinical Trials 40

STAT News

NOVEMBER 10, 2022

Now, a team led by the Bay Area-based biotech PACT Pharma and researchers at the University of California, Los Angeles have infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects.

DNA 98

DNA Scientist Research 98

STAT News

MARCH 6, 2023

Determined to prove his doctors wrong, Aldrich got his tumor genetically sequenced and arranged for a German biotech, CeGaT, to design an experimental neoantigen vaccine that he received in 2019, according to Jacobs and an account Aldrich gave to an online cancer publication.

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98

pharmaphorum

SEPTEMBER 20, 2022

Bharat Biotech, an Indian company that specialises in vaccines, announced at the beginning of September that it had received emergency use approval for its Incovacc product. The vaccine is a recombinant replication deficient adenovirus vectored vaccine, which the biotech developed in partnership with Washington University, St.

Vaccination 98

Vaccination Vaccine Immune Response Antibody 98

The Pharma Data

NOVEMBER 18, 2021

Bristol Myers Squibb Company (NYSEBMY) moment blazoned five innovative biotech startups as winners of the company’s 2021 Golden Ticket Contests. A private,non-profit institution, LabCentral was innovated in 2013 as a helipad for high implicit life- lores and biotech startups. In certain countries outside theU.S.,

Development 52

Development Scientist Medicine Clinical Development 52

Delveinsight

DECEMBER 8, 2020

It is being estimated that this IPO if successful, will be the biggest debut on record for Canadian biotech. And now the next step towards bolstering its strategic presence in the cell & gene therapy market, Bayer has collaborated with Bay Area-based Atara Biotherapeutics.

Licensing 52

Licensing Licensing Gene Therapy Antibody 52

The Pharma Data

SEPTEMBER 15, 2020

Amgen is a proud sponsor of MBC BioLabs, assisting high-potential and innovative early-stage life science and biotech companies accelerating development of new therapies to improve human health. Congratulations to both companies and their scientific entrepreneurs.”

Life Science 52

Life Science Protein Antibody Scientist 52

Drug Discovery World

NOVEMBER 8, 2023

The presentations include: Philipp Spycher, PhD, CEO, Araris Biotech AG, on: ‘Inducing significant and efficient tumour growth inhibition vs trastuzumab deruxtecan using two different Topo1 inhibitors (DAR4) and peptide linkers for payload conjugation to trastuzumab’.

Antibody 64

Antibody Engineer Protein Scientist 64

Pharmaceutical Technology

JUNE 2, 2023

San Francisco-based biotech Eikon Therapeutics has made waves in the bay after managing to raise $106m in its Series C funding round. The company also gained a suite of preclinical assets from San Francisco-based biotech Cleave Therapeutics.

Protein 130

Protein Development Clinical Development DNA 130